In the context of atherosclerosis, IL-22 deficiency is linked to lowered expression of RegIIIβ and RegIIIγ antimicrobial peptides, altered barrier function, and elevated serum LPS levels, therefore positioning IL-22 as an important player at the intestinal barrier needed to protect from the disease development. The gene discussed is IL22; the disease is atherosclerosis.